HMN insider sale: CEO disposes 5,000 shares under 10b5-1 plan

Rhea-AI Filing Summary

Horace Mann (HMN) President & CEO and Director Marita Zuraitis reported an open-market sale of 5,000 shares of common stock on 11/03/2025 under a pre-set Rule 10b5-1 trading plan adopted on 11/18/2024.

The weighted average sale price was $44.173, with trade prices ranging from $43.83 to $44.39. Following the transaction, she beneficially owns 288,788.422 shares, comprising 212,474.422 vested RSUs and 76,314 common shares. Ownership is reported as direct.

Insider Trade Summary

Net Seller: 5,000 shares ($220,865)

Net Sell 1 txn

Insider ZURAITIS MARITA

Role President & CEO

Sold 5,000 shs ($221K)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,000	$44.173	$221K

Holdings After Transaction: Common Stock — 288,788.422 shares (Direct)

Footnotes (1)

1. The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.83 to $44.39. Represents 212,474.422 vested restricted stock units and 76,314 shares of Common Stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZURAITIS MARITA

(Last) (First) (Middle)

1 HORACE MANN PLAZA

(Street)

SPRINGFIELD IL 62715

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HORACE MANN EDUCATORS CORP /DE/ [ HMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	11/03/2025		S		5,000	D	$44.173(2)	288,788.422(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.83 to $44.39.

3. Represents 212,474.422 vested restricted stock units and 76,314 shares of Common Stock.

Remarks:

	Linea K. Michael, Attorney in Fact for Marita Zuraitis	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HMN's CEO report on Form 4?

An open-market sale of 5,000 shares of common stock on 11/03/2025.

At what price did HMN shares sell in the reported trade?

The weighted average price was $44.173, with a range of $43.83 to $44.39.

Was the HMN trade under a Rule 10b5-1 plan?

Yes. It was executed under a Rule 10b5-1 plan adopted on 11/18/2024.

How many HMN shares does the CEO own after the trade?

Beneficial ownership is 288,788.422 shares reported as direct.

What makes up the CEO’s HMN beneficial holdings?

It includes 212,474.422 vested RSUs and 76,314 common shares.

What is the CEO’s relationship to HMN?

She is President & CEO and a Director.